SCHEMBL5587475

SCHEMBL5587475

CCCCc1c(F)cc(OC(=O)O)c(O)c1CCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.43
HCAR3 P49019 2/20 0.38
HCAR2 Q8TDS4 2/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ESR1 P03372 3/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
FFAR1 O14842 2/20 0.35
AKR1C4 P17516 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
SMPD3 Q9NY59 1/20 0.34
NCEH1 Q6PIU2 1/20 0.34
LTB4R Q15722 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588845 0.95 ALOX5 (0.49) ALOX5HCAR3HCAR2ESR1AKR1C4
SCHEMBL5589714 0.94 ALOX5 (0.51) ALOX5HCAR3HCAR2ESR1AKR1C4
SCHEMBL5589780 0.94 ALOX5 (0.51) ALOX5HCAR3HCAR2ESR1AKR1C4
SCHEMBL5588670 0.94 ALOX5 (0.51) ALOX5HCAR3HCAR2ESR1AKR1C4
SCHEMBL5589440 0.94 ALOX5 (0.51) ALOX5HCAR3HCAR2ESR1AKR1C4
SCHEMBL5587274 0.94 ALOX5 (0.51) ALOX5HCAR3HCAR2ESR1AKR1C4
SCHEMBL6233333 0.91 ALOX5 (0.41) ALOX5HCAR3HCAR2NPC1HPGD
SCHEMBL5588399 0.91 LDHA (0.38) ALOX5HCAR2FFAR1LTB4RLTB4R2
SCHEMBL5677838 0.86 ALOX5 (0.41) ALOX5HCAR3HCAR2NPC1HPGD
SCHEMBL5920563 0.85 ALOX5 (0.40) ALOX5HCAR3HCAR2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALOX5 188/4885HCAR3 2616/4885HCAR2 3141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.